Stay up-to-date on the world of healthcare

The growing cost burden on the NHS makes it increasingly important that savings are found where possible. One common and relatively straightforward approach to saving money is by switching patients from one branded medicine to a lower-priced, bioequivalent alternative brand.

Here we guide you through the benefits of Pharmly Analytics and Pharmly Cloud Data to help you understand which is the best fit for your needs.

In this blog we’ll guide you through the Patient and Medicine Journey. The aim is to help you understand how patients in the United Kingdom get their medicines and where these medicines originate from. Pharmly Cloud Data offers a range of datasets that cover (parts of) this journey.

Find out how you can get access to live UK healthcare data in Excel with just 7 simple steps. Using the Pharmly Cloud Data REST API you are just a few steps away from accessing all the data you need.

In April 2021, a number of Clinical Commissioning Groups (CCGs) were consolidated: 38 of the CCGs became 9, taking the total number of CCGs down to 106. It’s another step in the larger restructuring plan of the National Health Service (NHS). The next release of prescribing data, expected half June 2021, will be grouped differently.

The richest source of information in UK healthcare is the prescribing dataset. Understanding the medications prescribed, down to individual GP surgeries, can offer invaluable (anonymised) information which people use to shape regional health policies, monitor disease trends, and guide company portfolio strategies.

The richest source of information in UK healthcare is the prescribing dataset. Understanding the medications prescribed, down to individual GP surgeries, can offer invaluable (anonymised) information which people use to shape regional health policies, monitor disease trends, and guide company portfolio strategies.